| The company announced that Steven Miller, Ph.D. and Jack Weinstein will assume expanded responsibilities: Miller, currently Catalyst's Vice President, Pharmaceutical Development and Project Management, will assume additional duties as Catalyst's Chief Scientific Officer; and Weinstein, currently Catalyst's Vice President, Treasurer and CFO, will assume formal responsibility for Catalyst's business development activities. The company also announced that the board has extended the expiration date of McEnany's employment agreement with the company from November 8, 2009 to November 8, 2011. :theflyonthewall.com |
